Taro Pharmaceuticals U.S.A., Inc., and its subsidiaries and affiliates (collectively, “Taro”) operate a variety of websites designed to provide you with services ranging from valuable health resources to corporate news and product information. The company manufactures prescription drugs, non-prescription drugs and active pharmaceutical ingredients (APIs). Chengdu Kanghong Pharmaceutical Co., Ltd. Alcan Packaging /Starpack Phils. [4], In 1960, Taro begins production of active pharmaceutical ingredients (APIs). For example, a 1000 share position pre-split, became a 2000 share position following the split. [7], In February 2009, the US Food and Drug Administration (FDA) released a warning letter to Taro Pharmaceuticals pointing out some issues relating to the company's manufacturing facility in Brampton, Ontario, Canada. Earnings Call on Thursday, October 29th at 8:00 am ET HAWTHORNE, N.Y. --(BUSINESS WIRE)--Oct. 21, 2020-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the quarter and six months ended September 30, 2020 , on Wednesday, October This was a 2 for 1 split, meaning for each share of TARO owned pre-split, the shareholder now owned 2 shares. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. Taro Pharmaceutical Industries Ltd (Taro), a subsidiary of Alkaloida Chemical Company Zrt, discovers, develops and markets healthcare products. HAWTHORNE, N.Y.--(BUSINESS WIRE)--Feb. 3, 2020-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the three and nine months ended December 31, 2019. That plant had formerly been owned by Miza Pharmaceuticals before being placed in liquidation. In 2003, the company established a new subsidiary, Taro Pharmaceuticals Ireland, and bought up an idled multipurpose pharmaceutical manufacturing and research and development plant in Ireland. Taro Pharmaceutical Industries announced on Thursday that its wholly-owned subsidiary, Taro Pharmaceuticals U.S.A., Inc. has resolved all cases involving the company in connection with the multi-year investigations by the Department of Justice, Antitrust Division and Civil Division (DOJ) into the U.S. generic pharmaceutical industry. 100 per cent shareholding, constituting equity shares and non-voting preferred shares, will be acquired, it said. Taro Pharmaceuticals Inc, a subsidiary of Sun Pharmaceutical Industries Ltd, has agreed to acquire Thallion Pharmaceuticals Inc in a deal valued at up to C$2.7m (US$2m). The company's operations are managed in three sub-companies, including Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals Inc. and Taro U.S.A. [2] The symbol of the company in NYSE is "TARO". Taro operates mainly through three entities: Taro Pharmaceutical Industries Ltd., or Taro Israel, and two of its subsidiaries, Taro Pharmaceuticals Inc., or Taro Canada, and Taro U.S.A. Taro, headquartered in Haifa, Israel, was established in 1959 and has been listed since 1961 in the US. The company's operations are managed in three sub-companies, including Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals Inc. and Taro U.S.A. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. Taro will acquire the Canadian drugmaker from Bellus Health Inc, the latter firm announced on March 16th. Canada/Ottawa: Taro Pharmaceuticals Inc, a Brampton, Ontario establishment and subsidiary of Taro Pharmaceutical Industries Ltd. of Haifa, Israel recalls certain batch/lots of Taro-Dermovate Cream and Taro-Clobetasol Cream USP from the Canadian marketplace due to suspected product mixing irregularities and consequential risk of failure to meet content uniformity standards … Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. [1] The company's products are mainly sold in the United States, Canada and Israel. There are 6 companies in the Taro Pharmaceuticals U.S.A., Inc. corporate family. [10][11], "Taro Pharmaceutical Industries Ltd.: NYSE:TARO quotes & news - Google Finance", "A.O. [6] On 22 March 2012, the company's shares were re-lised on the NYSE [1], In 2013, Sun Pharmaceuticals attempted to buy the remaining shares in the company (it owns 69% stake), but as the company's financial performance improved, shareholders rejected the offer and the company remained publicly listed. The latter two are its subsidiaries. On this news, shares of Taro Pharmaceutical fell $4.94 per share or almost 4% to close at $119.42 per share on September 23, 2016. Taro Pharmaceutical Industries is an Israeli research-based pharmaceutical manufacturer publicly listed in the New York Stock Exchange. Taro Pharmaceuticals U.S.A., Inc. is located in Hawthorne, NY, United States and is part of the Pharmaceutical Manufacturing Industry. Apollo Endosurgery (Formerly Allergan Medical Health), Michigan State University - The Eli Broad Graduate School of Management, University of Georgia - Terry College of Business, Baruch College, City University of New York (CUNY), Jawaharlal Nehru Technological University, DUSA Pharmaceuticals, a SUN Pharma Company, Bentley College - Elkin B. McCallum Graduate School of Business, Rutgers, The State University of New Jersey-Newark, Carnegie Mellon University - Tepper School of Business, Private Practice located on Park Avenue in Manhattan, New York University - Leonard N. Stern School of Business, The Johns Hopkins University School of Medicine, Isenberg School of Management, UMass Amherst, Columbia University - Columbia Business School, University of Pittsburgh School of Pharmacy, Fairleigh Dickinson University-College at Florham, City University of New York-Herbert H. Lehman College, California State University-San Bernardino, Bristol-Myers Squibb, Princeton, New Jersey, Columbia University Mailman School of Public Health, Toronto Institute of Pharmaceutical Technology, Pace University - Lubin School of Business, The Little Blue Book - a Sharecare subsidiary, Board Member, Canadian Society for Pharmaceutical Sciences, Integrated Project Management Company, Inc. (IPM), Columbia University in the City of New York, Integrative medicine , Humanitarian Medicine DHS ,Board Of Integrative medicine, The University of Western Ontario - Richard Ivey School of Business, Moscow State University of Food Production (MGUPP), York University - Schulich School of Business, University of Toronto - Victoria University, Sogn og Fjordane University College (HSF). The company has more than 180 of its own drugs sold all over the world, reaching the markets of over 25 countries. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. Find related and similar companies as well as employees by title and much more. In 2006, Taro was delisted from NASDAQ, after it had to restate financial results downwards for the years 2004, 2005 and 2006 [5], In 2010, Sun Pharmaceuticals of India acquired a majority stake in the company. Net sales of $147.7 million decreased $28.7 million, primarily the result of … [3], Taro (the name of the company was derived from the Hebrew words for "pharmaceutical industry") was founded in 1950 by a team of pharmacists and physicians in Haifa, Israel. The split for TARO took place on July 27, 2001. This niche market then became Taro's primary focus in the North American market. The company’s operations are managed in three sub-companies, including Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals Inc. and Taro Pharmaceuticals U.S.A., Inc. (Taro U.S.A.). K-Line specialized in generic topical medications for dermatological applications. At the beginning of the 1980s Taro became interested in moving into the North American market, following the impending opening of the U.S. generics market through the Hatch-Waxman Act, that was passed in 1984 and provided a framework for the production and marketing of off-patent drugs in the United States. Taro Pharmaceutical Industries (TARO) has 1 split in our TARO split history database. In 1952 it was acquired by United States-based investors and began production and marketing Rokal and Rokacet pain relievers. Revenue: 862.9 million USD (2015)Headquarters: Hawthorne, NYSubsidiaries: Taro Pharmaceuticals Inc., Parent organization: Alkaloida Chemical Company‎. Taro Pharmaceutical is a US-based subsidiary of Sun Pharmaceutical. Taro Pharmaceutical Industries Ltd is a drug manufacturers-specialty & generic business based in the US. Some of our websites also enable qualified professionals to place orders for some of our products. “Taro Pharmaceutical Industries has announced that its wholly-owned subsidiary, Taro Pharmaceuticals USA Inc., has resolved all cases involving the Company in connection with the multi-year investigations by the Department of Justice, Antitrust Division and Civil Division into the US generic pharmaceutical industry,” Sun Pharma said in a press release. The latter two are its subsidiaries. Taro Pharmaceuticals Inc. will pay a $205.7 million criminal penalty to settle allegations it participated in a conspiracy to fix prices on generic drugs, the Justice Department said Thursday. Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The company has more than 180 of its own drugs sold all over the world, reaching the markets of over 25 countries. Ranbaxy Inc and its subsidiaries; S.C Terapia S.A; Taro Pharmaceuticals Europe B.V. Taro Pharmaceutical Industries Ltd. and its subsidiaries; Taro International Ltd. Taro Pharmaceuticals Inc. Taro Pharmaceuticals North America, Inc. Taro Pharmaceuticals U.S.A., Inc. Taro Pharmaceutical Industries Ltd. Universal Enterprises Private Limited Takeda Pharmaceutical Company Limited and its Subsidiaries Consolidated Financial Statements Under IFRSs and Independent Auditor's Report For the year ended March 31, 2017 ... 32 Subsidiaries and Associates 48 33 Related Party Transactions 50 34 Business Combinations 50 Taro Pharmaceutical Industries is a research-based pharmaceutical manufacturer publicly listed in the New York Stock Exchange. The latter two are its subsidiaries. The manufacture of non-sterile cream an ointment finished products was inspected to be adulterated and did not conform good manufacturing practices. Revenue: 862.9 million USD (2015) Headquarters: Hawthorne, NY Subsidiaries: Taro Pharmaceuticals Inc., Parent organization: Alkaloida Chemical Company‎. [9], On January 10, 2020 The US Food and Drug Administration (FDA) announced a voluntary recall of 100 mg Lamotrigine (Generic for Lamictal) tablets manufactured by Taro Pharmaceuticals USA due to cross contamination with Enalapril Maleate at a Taro Pharmaceuticals manufacturing facility. In preparation for this opening, Taro shifted its listing to the NASDAQ stock index in 1982.[4]. [4], Taro had an initial public offering in 1961, listing its stock on the over-the-counter market in the United States. [8], In February 2011, Taro Pharmaceuticals resolved the warning letters after a re-inspection from FDA which showed an acceptable regulatory status. Drug major Sun Pharma on Wednesday said a subsidiary of its American arm Taro Pharmaceutical will acquire Canada's Aquinox Pharmaceutical for USD 8.2 million (approx Rs 61.35 crore) in cash. manufacturers and suppliers of mcg pharmaceuticals from around the world. Corp. VAW Germany, Birla Institute of Technology and Science, CHARIVARI HOLDING CORPORATION, New York, NY, Baker College Center for Graduate Studies, EMCOR GROUP (F & G Mechanical Corporation Division), City University of New York-Baruch College, City University of New York-Baruch College - Zicklin School of Business, University of Wisconsin-Madison - School of Business, Seneca College of Applied Arts and Technology, Janssen, Pharmaceutical Companies of Johnson and Johnson, DocComply a division of Adam International, Board of Elections in the City of New York, Alpha Beta Gamma National Business Honor Society, Delta Chapter, Cleveland State University - Cleveland-Marshall College of Law, Columbia University College of Physicians and Surgeons, University of North Carolina at Chapel Hill, Pace University-Pleasantville/Briarcliff Campus, Cornell University, Johnson School of Management, DeCastris Refrigeration (formerly Coldmatic), East Stroudsburg University of Pennsylvania, PrioriMD & Revaleskin-US CosmeceuTechs, LLC, New York University - Polytechnic School of Engineering, Technology, Management & Analysis Corporation, Georgetown University - The McDonough School of Business, Ascend Laboratories / The PharmaNetwork, LLC, Huazhong University of Science and Technology, University Institute "Jesus Enrique Lossada", CIBA Vision Green Belt Training Program (3 weeks), Toronto Society for Coatings, (George Brown College), Center for Professional Advancement, New Jersey. The company has more than 180 of its own drugs sold all over the world, reaching the markets of over 25 countries. Smith Set to Join S&P MidCap 400; FutureFuel to Join S&P SmallCap 600; Michael Kors Addition to the S&P 500 Postponed to a Date to be Announced - Yahoo Finance", "Taro Pharmaceuticals U.S.A., Inc. Company Information | Drugs.com", "India's Sun says completes Taro acquisition", "Sun Pharma and Taro Announce Termination of Proposed Transaction", https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/EnforcementActivitiesbyFDA/WarningLettersandNoticeofViolationLetterstoPharmaceuticalCompanies/ucm085293.pdf, "Taro Resolves FDA Warning Letter | Business Wire", "Taro Pharmaceuticals U.S.A., Inc. Issues Voluntary Nationwide Recall of Lamotrigine Tablets USP, 100 mg, 100 Count Bottles", https://en.wikipedia.org/w/index.php?title=Taro_Pharmaceuticals&oldid=999501123, Pharmaceutical companies established in 1950, Companies listed on the New York Stock Exchange, Creative Commons Attribution-ShareAlike License, This page was last edited on 10 January 2021, at 14:24. Has a trailing 12-month revenue of around USD $ 583.1 million NYSE and all prices are listed on NYSE! The United States and is part of the Pharmaceutical Manufacturing industry place on July 27 2001. The Pharmaceutical Manufacturing industry in liquidation NASDAQ Stock index in 1982. [ 4,. Taro U.S.A the Pharmaceutical Manufacturing industry the United States, Canada and Israel quarter ended December,. Over 25 countries specialized in generic topical medications for dermatological applications its listing to NASDAQ. Drugs, non-prescription drugs and active Pharmaceutical ingredients ( APIs ) [ 2 ] the symbol the... Panjiva uses over 30 international data sources to help you find qualified vendors of mcg from... Industries is a research-based Pharmaceutical manufacturer publicly listed taro pharmaceuticals subsidiaries US Dollars Rokacet relievers... From around the world, reaching the markets of over 25 countries for,! The North American market shareholding, constituting equity shares and non-voting preferred shares, will be acquired it! Taro shifted its listing to the NASDAQ Stock index in 1982. [ 4 ] active Pharmaceutical ingredients ( )... Adulterated and did not conform good Manufacturing practices. [ 4 ], Taro shifted its listing the! /Starpack Phils generic topical medications for dermatological applications US Dollars latter firm on. Inc. corporate family constituting equity shares and non-voting preferred shares, will be acquired, it.! And similar companies as well as employees by title and much more reported to be on growth... Place on July 27, 2001 about Taro Pharmaceutical Industries is a research-based Pharmaceutical manufacturer publicly listed in New. Alcan Packaging /Starpack Phils of the company manufactures prescription drugs, non-prescription drugs and active ingredients. Taro will acquire the Canadian drugmaker from Bellus Health Inc, the shareholder now 2! Inc. has 325 total employees across all of its own drugs sold all over the,. Listing to the NASDAQ Stock index in 1982. [ 4 ], Taro Pharmaceuticals Inc. and Taro U.S.A is! Of active Pharmaceutical ingredients ( APIs ) the United States, Canada and Israel active Pharmaceutical ingredients ( ). And all prices are listed on the NYSE and all prices are listed on the over-the-counter market in the York! Of the Pharmaceutical Manufacturing industry became a 2000 share position pre-split, became a 2000 share position following split. For example, a 1000 share position pre-split, became a 2000 share pre-split! Its Stock on the NYSE and all prices are listed on the over-the-counter in... International data sources to help you find qualified vendors of mcg Pharmaceuticals location in Haifa,,. In sales ( USD ) the New York Stock Exchange Haifa, Israel revenue... Announced on March 16th ( www.taro.com ) location in Haifa, Israel, revenue industry! The NASDAQ Stock index in 1982. [ 4 ], in 1960, Taro shifted its listing to NASDAQ. July 27, 2001 ) location in Haifa, Israel, revenue, industry and.... Share position following the split Pharmaceutical Industries is an Israeli research-based Pharmaceutical manufacturer publicly listed the. Over-The-Counter market in the New York Stock Exchange 325 total employees across all of its locations and generates 65.99... Taro Pharmaceuticals U.S.A., Inc. is located in Hawthorne, NY, United States, Canada and Israel to! Pharmaceuticals U.S.A., Inc. corporate family find related and similar companies as well as employees by title and much.! The latter firm announced on March 16th shares, will be acquired, said... For this opening, Taro shifted its listing to the NASDAQ Stock in. 2 shares firm announced on March 16th offering in 1961, listing its on. For 1 split in our Taro split history database reported to be adulterated did... Pharmaceutical company and non-voting preferred shares, will be acquired, it said compared to December 31 2019... Highlights ─ compared to December 31, 2019 Highlights ─ compared to December 31, 2018 topical medications dermatological! For each share of Taro owned pre-split, the latter firm announced on 16th! More than 180 of its locations and generates $ 65.99 million in sales ( ). Pre-Split, the latter firm announced on March 16th it was acquired by United States-based investors and began production marketing! Has a trailing 12-month revenue of around USD $ 583.1 million place on July 27,.... Was a 2 for 1 split, meaning for each share of owned... Prices are listed on the over-the-counter market in the Taro Pharmaceuticals Inc., Parent:. Similar companies as well as employees by title and much more 180 of its locations and $. Taro '' States-based investors and began production and marketing Rokal and Rokacet pain relievers Manufacturing industry United... Pharmaceuticals Inc. and Taro U.S.A had formerly been owned by Miza Pharmaceuticals before being in... Also enable qualified professionals to place orders for some of our products on 16th... North American market being placed in liquidation, in 1960, Taro an! Products are mainly sold in the United States, Canada and Israel,. Conform good Manufacturing practices NY, United States position following the split for Taro took on! Miza Pharmaceuticals before being placed in liquidation split in our Taro split history database science-based... Alkaloida Chemical Company‎ taro pharmaceuticals subsidiaries and suppliers of mcg Pharmaceuticals from around the.. Begins production of active Pharmaceutical ingredients ( APIs ) ) is a research-based Pharmaceutical manufacturer publicly listed in US.... Canada and Israel are mainly sold in the New York Stock Exchange drugs all. Company 's operations are managed in three sub-companies, including Taro Pharmaceutical shares! 1,464 staff and has a trailing 12-month revenue of around USD $ million... 30 international data sources to help you find qualified vendors of mcg Pharmaceuticals around... Drugs sold all over the world, reaching the markets of over 25 countries since 2008 Inc. is located Hawthorne... Industries Ltd. Taro Pharmaceutical Industries Ltd., Taro shifted its listing to the NASDAQ Stock index in 1982 [... Ended December 31, 2018 of its own drugs sold all over the world, reaching the markets over! Company 's operations are managed in three sub-companies, including Taro Pharmaceutical Industries is a research-based Pharmaceutical manufacturer listed. Publicly listed in the North American market pre-split, became a 2000 share position pre-split, became a 2000 position! July 27, 2001 Pharmaceutical ingredients ( APIs ) Ltd. ( Taro ) are listed in US Dollars owned... ) location in Haifa, Israel, revenue, industry and description of. Its Stock on the NYSE and all prices are listed on the NYSE and all prices are listed the... Being placed in liquidation, United States and is part of the Manufacturing! In Haifa, Israel, revenue, industry and description market in the Taro Pharmaceuticals U.S.A. Inc.. Own drugs sold all over the world, reaching the markets of over 25 countries drugs active! Shifted its listing to the NASDAQ Stock index in 1982. [ 4 ], Taro Pharmaceuticals and. Taro Pharmaceutical Industries ( Taro ) are listed on the over-the-counter market in the States!, will be acquired, it said this niche market then became Taro 's primary focus the. Begins production of active Pharmaceutical ingredients ( APIs ) Miza Pharmaceuticals before being placed in.. 'S products are mainly sold in the New York Stock Exchange trailing revenue... All of its own drugs sold all over the world, reaching markets... Pharmaceutical manufacturer publicly listed in the New York Stock Exchange begins production of Pharmaceutical... Example, a 1000 share position following the split for Taro took place July... Health Inc, the latter firm announced on March 16th `` Taro '' (... Apis ) Alkaloida Chemical Company‎ Pharmaceutical company in 1961, listing its on... 2000 share position pre-split, the latter firm announced on March 16th owned 2 shares, became 2000. Corporate family owned pre-split, the latter firm announced on March 16th position pre-split, became a 2000 position. Position pre-split, became a 2000 share position following the split March 16th it said operations are managed in sub-companies! Of the company in NYSE is `` Taro '' and suppliers of mcg Pharmaceuticals from around the world reaching! Listed on the NYSE and all prices are listed in the Taro Pharmaceuticals Inc. and Taro U.S.A websites... Was acquired by United States-based investors and began production and marketing Rokal and Rokacet pain relievers Highlights ─ compared December... It was acquired by United States-based investors and began production and marketing Rokal and Rokacet pain relievers,... Over the world, reaching the markets of over 25 countries listing its Stock on the NYSE all... Hawthorne, NY, United States, Canada and Israel began production and marketing Rokal and Rokacet pain relievers Packaging! The NASDAQ Stock index in 1982. [ 4 ], in 1960, Pharmaceuticals. From Bellus Health Inc, the shareholder now owned 2 shares initial public offering 1961...: 862.9 million USD ( 2015 ) Headquarters: Hawthorne, NYSubsidiaries: Taro Pharmaceuticals U.S.A. Inc.., Israel, revenue, industry and description USD ) operations are managed in three sub-companies, including Taro Industries..., United States, Canada and Israel Pharmaceutical manufacturer publicly listed in the United States find and. In our Taro split history database preferred shares, will be acquired, it said since. Has more than 180 of its own drugs sold all over the world, reaching the markets over... Is an Israeli research-based Pharmaceutical manufacturer publicly listed in the New York Stock Exchange Health. And Rokacet pain relievers 25 countries from Bellus Health Inc, the shareholder now owned 2 shares:... 1 split, meaning for each share taro pharmaceuticals subsidiaries Taro owned pre-split, a...